These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19398874)
1. Plasma urotensin II as a marker for severity of rheumatic valve disease. Ozer O; Davutoglu V; Ercan S; Akcay M; Sari I; Sucu M; Celik A; Aksoy N; Cicek H; Al B Tohoku J Exp Med; 2009 May; 218(1):57-62. PubMed ID: 19398874 [TBL] [Abstract][Full Text] [Related]
2. The value of urotensin II in patients with left-sided rheumatic valvular regurgitation. Elmadbouh I; Ali Soliman M; Abdallah Mostafa A; Ahmed Heneish H Egypt Heart J; 2017 Jun; 69(2):133-138. PubMed ID: 29622967 [TBL] [Abstract][Full Text] [Related]
3. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Davutoglu V; Celik A; Aksoy M; Sezen Y; Soydinc S; Gunay N Eur J Heart Fail; 2005 Jun; 7(4):532-6. PubMed ID: 15921791 [TBL] [Abstract][Full Text] [Related]
4. Contribution of selected serum inflammatory mediators to the progression of chronic rheumatic valve disease, subsequent valve calcification and NYHA functional class. Davutoglu V; Celik A; Aksoy M J Heart Valve Dis; 2005 Mar; 14(2):251-6. PubMed ID: 15792187 [TBL] [Abstract][Full Text] [Related]
5. [The effect of tricuspid insufficiency on right ventricular performance in patients with valvular heart disease (author's transl)]. Schwarz F; Manthey J; Schuler G; Mäurer W; Mehmel H; Kübler W Z Kardiol; 1981 Jun; 70(6):466-71. PubMed ID: 7257501 [TBL] [Abstract][Full Text] [Related]
6. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension. Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441 [TBL] [Abstract][Full Text] [Related]
7. Coronary sinus dilatation. A simple additional echocardiographic indicator of severe rheumatic mitral and tricuspid valve disease. Kizilkan N; Davutoglu V; Erbagci H; Karagoz A; Akcay M; Sari I; Ercan S; Dogan A Saudi Med J; 2010 Feb; 31(2):153-7. PubMed ID: 20174730 [TBL] [Abstract][Full Text] [Related]
8. Underlying Rheumatic Disease: An Important Determinant of Outcome in Tricuspid Valve Repair. Munasur M; Naidoo D J Heart Valve Dis; 2016 Mar; 25(2):203-210. PubMed ID: 27989068 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease. Banerjee T; Mukherjee S; Ghosh S; Biswas M; Dutta S; Pattari S; Chatterjee S; Bandyopadhyay A PLoS One; 2014; 9(3):e90527. PubMed ID: 24603967 [TBL] [Abstract][Full Text] [Related]
10. Outcome of significant functional tricuspid regurgitation late after mitral valve replacement for predominant rheumatic mitral stenosis. Boyaci A; Gokce V; Topaloglu S; Korkmaz S; Goksel S Angiology; 2007; 58(3):336-42. PubMed ID: 17626989 [TBL] [Abstract][Full Text] [Related]
12. Progression of Tricuspid Regurgitation after Mitral Valve Replacement for Rheumatic Heart Disease. Q Tri HH; Vinh PN J Heart Valve Dis; 2017 May; 26(3):290-294. PubMed ID: 29092113 [TBL] [Abstract][Full Text] [Related]
13. Reduced exercise capacity in patients with tricuspid regurgitation after successful mitral valve replacement for rheumatic mitral valve disease. Groves PH; Lewis NP; Ikram S; Maire R; Hall RJ Br Heart J; 1991 Oct; 66(4):295-301. PubMed ID: 1747281 [TBL] [Abstract][Full Text] [Related]
14. Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease. Izumi C; Iga K; Konishi T J Heart Valve Dis; 2002 May; 11(3):353-6. PubMed ID: 12056726 [TBL] [Abstract][Full Text] [Related]
15. Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy. Lapp H; Boerrigter G; Costello-Boerrigter LC; Jaekel K; Scheffold T; Krakau I; Schramm M; Guelker H; Stasch JP Int J Cardiol; 2004 Mar; 94(1):93-7. PubMed ID: 14996481 [TBL] [Abstract][Full Text] [Related]
16. [Atrioventricular valve insufficiency and atrial geometry in orthotopic heart transplantation]. De Simone R; Lange R; Sack FU; Mehmanesh H; Hagl S Cardiologia; 1994 May; 39(5):325-34. PubMed ID: 8087814 [TBL] [Abstract][Full Text] [Related]
17. Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and atrial fibrillation. Kabukçu M; Arslantas E; Ates I; Demircioglu F; Ersel F Angiology; 2005; 56(2):159-63. PubMed ID: 15793605 [TBL] [Abstract][Full Text] [Related]
18. [Tricuspid valve insufficiency in patients with rheumatic mitral valve disease: angiographic diameter of the tricuspid ring and function of the right ventricle]. Hoffmeister HM; Karsch KR; Konz KH; Brilla C; Voelker W; Seipel L Z Kardiol; 1986 Jun; 75(6):329-33. PubMed ID: 3751219 [TBL] [Abstract][Full Text] [Related]
19. High levels of high-sensitivity C-reactive protein and uric acid can predict disease severity in patients with mitral regurgitation. Turker Y; Ekinozu I; Turker Y; Akkaya M Rev Port Cardiol; 2014 Nov; 33(11):699-706. PubMed ID: 25448796 [TBL] [Abstract][Full Text] [Related]
20. Relation between mitral regurgitation and platelet activation. Tse HF; Lau CP; Cheng G J Am Coll Cardiol; 1997 Dec; 30(7):1813-8. PubMed ID: 9385912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]